Corrigendum: MRI radiomics predicts progression-free survival in prostate cancer

Front Oncol. 2023 Jan 13:12:1125641. doi: 10.3389/fonc.2022.1125641. eCollection 2022.

Authors

Yushan Jia¹, Shuai Quan², Jialiang Ren², Hui Wu³, Aishi Liu³, Yang Gao³, Fene Hao³, Zhenxing Yang³, Tong Zhang¹, He Hu¹

Affiliations

¹ Affiliated Hospital, Inner Mongolia Medical University, Hohhot, China.
² Department of Pharmaceuticals Diagnosis, GE Healthcare (China), Shanghai, China.
³ Department of Radiology, Affiliated Hospital of Inner Mongolia Medical University, Hohhot, China.

Abstract

[This corrects the article DOI: 10.3389/fonc.2022.974257.].

Keywords: magnetic resonance imaging; predictions; progression-free survival; prostate cancer; radiomics.

Copyright © 2023 Jia, Quan, Ren, Wu, Liu, Gao, Hao, Yang, Zhang and Hu.

Publication types

Published Erratum